These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 35785339)

  • 21. Individualized quantification of brain β-amyloid burden: results of a proof of mechanism phase 0 florbetaben PET trial in patients with Alzheimer's disease and healthy controls.
    Barthel H; Luthardt J; Becker G; Patt M; Hammerstein E; Hartwig K; Eggers B; Sattler B; Schildan A; Hesse S; Meyer PM; Wolf H; Zimmermann T; Reischl J; Rohde B; Gertz HJ; Reininger C; Sabri O
    Eur J Nucl Med Mol Imaging; 2011 Sep; 38(9):1702-14. PubMed ID: 21547601
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biomarkers of Alzheimer's disease among Mexican Americans.
    O'Bryant SE; Xiao G; Edwards M; Devous M; Gupta VB; Martins R; Zhang F; Barber R;
    J Alzheimers Dis; 2013; 34(4):841-9. PubMed ID: 23313927
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systolic Blood Pressure Is Associated with Increased Brain Amyloid Load in Mild Cognitively Impaired Participants: Alzheimer's Disease Neuroimaging Initiatives Study.
    Fungwe TV; Ngwa JS; Johnson SP; Turner JV; Ramirez Ruiz MI; Ogunlana OO; Bedada FB; Nadarajah S; Ntekim OE; Obisesan TO
    Dement Geriatr Cogn Disord; 2023; 52(1):39-46. PubMed ID: 36808103
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of APOE Genotypes and Chronic Traumatic Encephalopathy.
    Atherton K; Han X; Chung J; Cherry JD; Baucom Z; Saltiel N; Nair E; Abdolmohammadi B; Uretsky M; Khan MM; Shea C; Durape S; Martin BM; Palmisano JN; Farrell K; Nowinski CJ; Alvarez VE; Dwyer B; Daneshvar DH; Katz DI; Goldstein LE; Cantu RC; Kowall NW; Alosco ML; Huber BR; Tripodis Y; Crary JF; Farrer L; Stern RA; Stein TD; McKee AC; Mez J
    JAMA Neurol; 2022 Aug; 79(8):787-796. PubMed ID: 35759276
    [TBL] [Abstract][Full Text] [Related]  

  • 25. APOE effects on regional tau in preclinical Alzheimer's disease.
    Young CB; Johns E; Kennedy G; Belloy ME; Insel PS; Greicius MD; Sperling RA; Johnson KA; Poston KL; Mormino EC; ;
    Mol Neurodegener; 2023 Jan; 18(1):1. PubMed ID: 36597122
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of β-amyloid positivity on cerebral metabolism in cognitively normal seniors.
    Bozoki AC; Zdanukiewicz M; Zhu DC;
    Alzheimers Dement; 2016 Dec; 12(12):1250-1258. PubMed ID: 27445158
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CSF cutoffs for MCI due to AD depend on APOEε4 carrier status.
    Marizzoni M; Ferrari C; Babiloni C; Albani D; Barkhof F; Cavaliere L; Didic M; Forloni G; Fusco F; Galluzzi S; Hensch T; Jovicich J; Marra C; Molinuevo JL; Nobili F; Parnetti L; Payoux P; Ranjeva JP; Ribaldi F; Rolandi E; Rossini PM; Salvatore M; Soricelli A; Tsolaki M; Visser PJ; Wiltfang J; Richardson JC; Bordet R; Blin O; Frisoni GB
    Neurobiol Aging; 2020 May; 89():55-62. PubMed ID: 32029236
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Respective influence of beta-amyloid and APOE ε4 genotype on medial temporal lobe subregions in cognitively unimpaired older adults.
    de Flores R; Demeilliez-Servouin S; Kuhn E; Chauveau L; Landeau B; Delcroix N; Gonneaud J; Vivien D; Chételat G;
    Neurobiol Dis; 2023 Jun; 181():106127. PubMed ID: 37061167
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cerebral Amyloid Deposition Is Associated with Gait Parameters in the Mayo Clinic Study of Aging.
    Wennberg AMV; Savica R; Hagen CE; Roberts RO; Knopman DS; Hollman JH; Vemuri P; Jack CR; Petersen RC; Mielke MM
    J Am Geriatr Soc; 2017 Apr; 65(4):792-799. PubMed ID: 27869301
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Topographical APOE ɛ4 Genotype Influence on Cerebral Metabolism in the Continuum of Alzheimer's Disease: Amyloid Burden Adjusted Analysis.
    Seo EH; Kim SH; Park SH; Kang SH; Choo IH;
    J Alzheimers Dis; 2016 Sep; 54(2):559-68. PubMed ID: 27567846
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of tau deposition using
    Bullich S; Mueller A; De Santi S; Koglin N; Krause S; Kaplow J; Kanekiyo M; Roé-Vellvé N; Perrotin A; Jovalekic A; Scott D; Gee M; Stephens A; Irizarry M
    Alzheimers Res Ther; 2022 Jul; 14(1):105. PubMed ID: 35897078
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Greater medial temporal hypometabolism and lower cortical amyloid burden in ApoE4-positive AD patients.
    Lehmann M; Ghosh PM; Madison C; Karydas A; Coppola G; O'Neil JP; Huang Y; Miller BL; Jagust WJ; Rabinovici GD
    J Neurol Neurosurg Psychiatry; 2014 Mar; 85(3):266-73. PubMed ID: 23965289
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitative
    Zhao Q; Liu M; Ha L; Zhou Y;
    Front Neurol; 2019; 10():486. PubMed ID: 31156534
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    Chang Y; Li C; Yang H; Wu Y; Xu B; Zhang J; Wang R
    Front Neurosci; 2020; 14():745. PubMed ID: 32848542
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of Mexican Americans with mild cognitive impairment and Alzheimer's disease.
    O'Bryant SE; Johnson L; Balldin V; Edwards M; Barber R; Williams B; Devous M; Cushings B; Knebl J; Hall J
    J Alzheimers Dis; 2013; 33(2):373-9. PubMed ID: 22976076
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amyloid-PET Levels in the Precuneus and Posterior Cingulate Cortices Are Associated with Executive Function Scores in Preclinical Alzheimer's Disease Prior to Overt Global Amyloid Positivity.
    Ali DG; Bahrani AA; Barber JM; El Khouli RH; Gold BT; Harp JP; Jiang Y; Wilcock DM; Jicha GA
    J Alzheimers Dis; 2022; 88(3):1127-1135. PubMed ID: 35754276
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of Initial β-Amyloid Levels With Subsequent Flortaucipir Positron Emission Tomography Changes in Persons Without Cognitive Impairment.
    Knopman DS; Lundt ES; Therneau TM; Albertson SM; Gunter JL; Senjem ML; Schwarz CG; Mielke MM; Machulda MM; Boeve BF; Jones DT; Graff-Radford J; Vemuri P; Kantarci K; Lowe VJ; Petersen RC; Jack CR;
    JAMA Neurol; 2021 Feb; 78(2):217-228. PubMed ID: 33074304
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Associations between white matter microstructure and amyloid burden in preclinical Alzheimer's disease: A multimodal imaging investigation.
    Racine AM; Adluru N; Alexander AL; Christian BT; Okonkwo OC; Oh J; Cleary CA; Birdsill A; Hillmer AT; Murali D; Barnhart TE; Gallagher CL; Carlsson CM; Rowley HA; Dowling NM; Asthana S; Sager MA; Bendlin BB; Johnson SC
    Neuroimage Clin; 2014; 4():604-14. PubMed ID: 24936411
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    Ferrari-Souza JP; Lussier FZ; Leffa DT; Therriault J; Tissot C; Bellaver B; Ferreira PCL; Malpetti M; Wang YT; Povala G; Benedet AL; Ashton NJ; Chamoun M; Servaes S; Bezgin G; Kang MS; Stevenson J; Rahmouni N; Pallen V; Poltronetti NM; O'Brien JT; Rowe JB; Cohen AD; Lopez OL; Tudorascu DL; Karikari TK; Klunk WE; Villemagne VL; Soucy JP; Gauthier S; Souza DO; Zetterberg H; Blennow K; Zimmer ER; Rosa-Neto P; Pascoal TA
    Sci Adv; 2023 Apr; 9(14):eade1474. PubMed ID: 37018391
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comorbid Depression and Diabetes as a Risk for Mild Cognitive Impairment and Alzheimer's Disease in Elderly Mexican Americans.
    Johnson LA; Gamboa A; Vintimilla R; Cheatwood AJ; Grant A; Trivedi A; Edwards M; Hall JR; O'Bryant SE
    J Alzheimers Dis; 2015; 47(1):129-36. PubMed ID: 26402761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.